Pharmaceuticals, Biotechnology and Life Sciences
BOSTON–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24GMDA&src=ctag" target="_blank"gt;$GMDAlt;/agt; lt;a href="https://twitter.com/hashtag/ISCT2019?src=hash" target="_blank"gt;#ISCT2019lt;/agt;–Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced…
— Investigational Multi-Cancer Blood Test Detects Strong Signal for 12 Deadly Cancer Types When They are Still Localized, with 99…
— Phase 1/2 Multi-Center Clinical Trial to Begin Enrolling in Q4 2019 — SANTA MONICA, Calif. & BURLINGAME, Calif.–(BUSINESS WIRE)–Kite,…
Annual survey finds Lundbeck US is first among leading pharmaceutical companies in the eyes of patient groups. DEERFIELD, Ill.–(BUSINESS WIRE)–lt;a…
WALTHAM, Mass.–(BUSINESS WIRE)–Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and…
Preclinical and Clinical Data Demonstrate Advanced Deployment of Precision Medicine Tools to Analyze and Potentially More Effectively Intervene with Highly…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/conference?src=hash" target="_blank"gt;#conferencelt;/agt;–Goldfinch Bio, Inc., a biotechnology company focused on developing precision therapies for patients with kidney diseases,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Generation Bio, a company developing the first genetic medicines that can be re-dosed and titrated to effect for…
Survival Benefit Now Observed with KEYTRUDA in Combination with Chemotherapy in All Patient Populations (Regardless of PD-L1 Expression) and with…
Survival Benefit Now Observed with KEYTRUDA in Combination with Chemotherapy in All Patient Populations (Regardless of PD-L1 Expression) and with…